Search Results - Guillaume Pénaranda

Prevalence and characterization of NS5A resistance associated variants (RAVs) in patients who relapsed following exposure to NS5A inhibitors by Guillaume Penaranda, Philippe Halfon, Caroline Scholtès, Sofiane Mohamed, Vincent Leroy, Marc Bourlière, Denis Ouzan, Guillaume Pénaranda, Hacène Khiri, Laura Polverel, Fabien Zoulim, Marie-Ange Thélu, Sylvie Larrat

Connect to this object online.

Clinical resistance to dolutegravir assessed by next generation sequencing in pre-exposed raltegravir patients by Philippe Halfon, Guillaume Penaranda, Denis Ouzan, Patrick Philibert, Hacène Khiri, Sofiane Mohamed

Connect to this object online.

A cohort analysis of sexually transmitted infections among different groups of men who have sex with men in the early era of HIV pre-exposure prophylaxis in France by Christina K. Psomas, Guillaume Penaranda, Frederique Retornaz, Hacene Khiri, Marion Delord, Philippe Halfon, Patrick Philibert

Connect to this object online.

High Incidence of sexually transmitted infections in HIV negative MSM patients: a real-life prospective cohort study by Patrick Philibert, Guillaume Penaranda, Laurent Chiche, Stanislas Rebaudet, Claire Camus, Hacène Khiri, Marion Delord, Julie Allemand-Sourrieu, Philippe Halfon

Connect to this object online.

HCV kinetic and modeling analyses indicate similar time to cure among sofosbuvir combination regimens with daclatasvir, simeprevir or ledipasvir by Harel Dahari, Laetitia Canini, Frederik Graw, Susan L. Uprichard, EvaldoS A. Araujo, Guillaume Penaranda, Emilie Coquet, Aurélie Riso, Christophe Renou, Marc Bourlière, Scott J. Cotler, Philippe Halfon

Connect to this object online.